Antibody response to human immunodeficiency virus after primary infection

Journal of Infectious Diseases

Volumn 155, Issue 6, 1987, Pages 1113-1118

  Cooper, David A ^a,b   Imrie, Allison A ^a,b   Penny, Ronald ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; PRIORITY JOURNAL; SERODIAGNOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HIV; HIV ANTIBODIES; HOMOSEXUALITY; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC TECHNIQUES; MALE; SUPPORT, NON-U.S. GOV'T;

EID: 0023176265     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/155.6.1113     Document Type: Article

References (34)

1. Cooper DA, Gold J, Maclean P, Donovan B, Finlayson R, Barnes TG, Michelmore HM, Brooke P, Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985;1:537-40
2. Tindall B, Barber S, Donovan B, Barnes T, Roberts J, Kronenberg C, Gold J, Penny R, Cooper DA. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1987 (in press)
3. Ho DO, Sarngadharan MG, Resnick L, Dimarzo-Veronese F, Rota TR, Hirsch MS. Primary human T-Iymphotropic virus type III infection. Ann Intern Med 1985;103:880-3
4. Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet 1984;2:1376-7
5. Boiteux F, Vilmer E, Girot R, Muller J-Y, Rouzioux C, Chamaret S, Montagnier L. Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion. N Engl J Med 1985;312:648-9
6. Tucker J, Ludlam CA, Craig A, Philip I, Steel CM, Tedder RS, Cheingsong-Popov R, Macnicol MF, McClelland DBL, Boulton FE. HTLV-IlI infection associated with glandularfever- like illness in a haemophiliac. Lancet 1985;1:585
7. L’Age-Stehr J, Schwarz A, Offermann G, Langmaack H, Bennhold I, Niedrig M, Koch MA. HTLV-I1I infection in kidney transplant recipients [letter]. Lancet 1985;2:1361-2
8. Lindskov R, Lindhardt BO, Weismann K, Thomsen K, Bang F, Ulrich K, Wantzin G. Acute HTLV-III infection with roseola-like rash [letter]. Lancet 1986;1:447
9. McCray E, the Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Engl J Med 1986; 314:1127-32
10. Carne CA, Tedder RS, Smith A, Sutherland S, Elkington SG, Daly HM, Preston FE, Craske J. Acute encephalopathy coincident with seroconversion for anti-HTLV-I1I. Lancet 1985;2:1206-8
11. Ho DO, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-7
12. Piette AM, Tusseau F, Vignon O, Chapman A, Parrot G, Leibowitch J, Montagnier L. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-lII [letter]. Lancet 1986;1:852
13. Esteban JI, Shih JW-K, Tai C-C, Bodner AJ, Kay JWD, Alter HJ. Importance of Western blot analysis in predicting infectivity of anti-HTLV-IIIILAV positive blood. Lancet 1985;2:1083-6
14. Goedert JJ, Sarngadharan MG, Biggar RJ, Weiss SH, Winn OM, Grossman RJ, Greene MH, Bodner AJ, Mann DL, Strong OM, Gallo RC, Blattner WA. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet 1984;2:711-6
15. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC. Antibodies reactive with human T-Iymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984;224:506-8
16. Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzman O, Saimot AG, Rozenbaum W, Christol O, Gluckmann JE, Montagnier L, Chermann JC. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1984;1: 1253-6
17. Levy, IA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984;225:840-2
18. Imrie AA, Kehrer S, Smith GW, Penny R, Cooper DA. Seroimmunology of AIDS retrovirus infection. I. Use of immunofluorescent assay to confirm sera with ELISA reactivity. Pathology 1986;18:438-43
19. Schupbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 1984;224:503-5
20. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, the AIDS Seroepidemiology Collaborative Working Group, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA 1985;253:221-5
21. Mortimer PP, Parry JV, Mortimer JY. Which anti-HTLV III/LAV assays for screening and confirmatory testing? Lancet 1985;2:873-7
22. Sydney AIDS Study Group. The Sydney AIDS Project. Med J Aust 1984;141:569-73
23. Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Nat! Acad Sci USA 1985;82: 5535-9
24. Sandstrom EG, Schooley RT, Ho DO, Byington R, Sarngadharan MG, MacLane ME, Essex M, Gallo RC, Hirsch MS. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion 1985; 25:308-12
25. Ulstrup JC, Skaug K, Figenschau KJ, 0rstavik I, Bruun IN, Petersen G. Sensitivity of Western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection [letter). Lancet 1986;1:1151-2
26. Ammann AJ, Kaminsky L, Cowan M, Levy JA. Antibodies to AIDS-associated retrovirus distinguish between pediatric primary and acquired immunodeficiency diseases. JAMA 1985;253:3116-8
27. Aiuti F, Rossi P, Sirianni MC, Carbonari M, Popovic M, Sarngadharan MG, Contu L, Moroni M, Romagnani S, Gallo RC. IgM and IgG antibodies to human T celllymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J 1985;291:165-6
28. Ludlam CA, Tucker J, Steel CM, Tedder RS, CheingsongPopov R, Weiss RA, McClelland DBL, Philip I, Prescott RJ. Human T-Iymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet 1985;2:233-6
29. Salahuddin SZ, Groopman JE, Markham PO, Sarngadharan MG, Redfield RR, McLane MF, Essex M, Sliski A, Gallo RC. HTLV-III in symptom-free seronegative persons. Lancet 1984;2:1418-20
30. Groopman JE, Hartzband PI, Shulman L, Salahuddin SZ, Sarngadharan MG, McLane MF, Essex M, Gallo RC. Antibody seronegative human T-lymphotropic virus type III (HTLV-III) infected patients with acquired immunodeficiency syndrome or related disorders. Blood 1985;66:742-4
31. Kuhnl P, Seidl S, Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results [letter). Lancet 1985;1:1222-3
32. Kenrick KG, Bolton W, Doran TJ. False-positive anti-HTLVIII assay results and HLA-DR4 [letter). Med J Aust 1985;143:88-9
33. Lange JMA, Coutinho RA, Krone WJA, Verdonck LF, Danner SA, van der Noordaa J, Goudsmit J. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lyrnphotropic virus. Br Med J 1986;292:228-30
34. Farthing C, Gazzard B. Acute illnesses associated with HTLVIII seroconversion. Lancet 1985;1:935-6